Social Media Press Releases

RSS

Showing Press Releases with Tag: monoclonal antibody

8/29/2005

MedImmune Licenses Worldwide Rights for Anti-Staphylococcal Antibody Program From GlaxoSmithKline

» read more
5/25/2005

Preclinical Data Support Link Between IL-9 and Airway Hyperresponsiveness Associated With Asthma

» read more
5/17/2005

Preliminary Phase 1 Data Show MedImmune’s Siplizumab Well Tolerated in CD2-Positive Lymphoma and Leukemia Patients

» read more
5/14/2005

Additional Safety Data Presented at PAS Annual Meeting on MedImmune’s Next-Generation Product to Help Prevent RSV Disease in High-Risk Infants

» read more
5/14/2005

Preliminary Analysis of Phase 2 Study Shows 53 Percent of Patients With Stage IV Metastatic Melanoma Survive One-Year Mark When Treated With Vitaxin(R)

» read more
4/15/2005

MedImmune Begins Dosing in Phase 1 Clinical Trial for Nasally Delivered Vaccine Designed to Help Prevent Common Childhood Respiratory Viral Diseases

» read more
1/11/2005

MedImmune Updates Investors at JPMorgan Healthcare Conference

» read more